AbbVie Inc. v. Novartis Vaccines and Diagnostics, Inc. et al
Filing
56
STIPULATION AND ORDER re 55 REGARDING BRIEFING SCHEDULE AND MOTION HEARING filed by Novartis Vaccines and Diagnostics, Inc. REGARDING BRIEFING SCHEDULE AND MOTION HEARING, 48 MOTION to Compel Arbitration and To Stay . Responses due by 7/7/2017. Replies due by 7/21/2017. Motion Hearing set for 8/17/2017 01:30 PM in Courtroom 5, 17th Floor, San Francisco before Edward M. Chen. Case Management Statement due by 11/9/2017. Initial Case Management Conference reset for 11/16/2017 09:30 AM in Courtroom 5, 17th Floor, San Francisco. Signed by Judge Edward M. Chen on 6/8/17. (bpfS, COURT STAFF) (Filed on 6/8/2017)
1
2
3
4
5
6
7
8
9
11
12
ATTORNEYS AT LAW
M C D ERMOTT W ILL & E MERY LLP
10
THOMAS P. STEINDLER (Pro Hac Vice)
tsteindler@mwe.com
MICHAEL V. O’SHAUGHNESSY (Pro Hac Vice)
moshaughnessy@mwe.com
MCDERMOTT WILL & EMERY LLP
500 N. Capitol St., N.W.
Washington, DC 20001
Tel: (202) 756-8000
Fax: (202 756-8087
MICHAEL A. MORIN (Pro Hac Vice)
michael.morin@lw.com
DAVID P. FRAZIER (Pro Hac Vice)
david.frazier@lw.com
ELISSA N. KNOFF (SBN: 309497)
elissa.knoff@lw.com
LATHAM & WATKINS LLP
555 Eleventh Street, NW, Suite 1000
Washington, D.C. 20004
Tel: (202) 637-2200
Fax: (202) 637-2201
WILLIAM G. GAEDE III (SBN: 136184)
wgaede@mwe.com
MCDERMOTT WILL & EMERY LLP
275 Middlefield Road, Suite 100
Menlo Park, CA 94025
Tel: (650) 815-7400
Fax: (650) 469-1470
GREGORY K. SOBOLSKI (SBN 267428)
gregory.sobolski@lw.com
LATHAM & WATKINS LLP
505 Montgomery St., Suite 2000
San Francisco, CA 94111
Tel: (415) 391-0600
Fax: (415) 395-8095
NICOLE CLOUSE (Pro Hac Vice)
nclouse@mwe.com
MCDERMOTT WILL & EMERY LLP
28 State Street
Boston, MA 02109
Tel: (617) 535-3841
Fax: (617) 535-3800
Attorneys for AbbVie Inc.
ANDREA MEGHROUNI-BROWN
(SBN 14823)
andrea.meghrouni-brown@grifols.com
GRIFOLS DIAGNOSTIC
SOLUTIONS INC.
4560 Horton Street
Emeryville, CA 94608
Tel: (510) 923-5237
Fax: (510) 923-5253
See attached list of co-counsel.
13
14
15
Attorney for Grifols Worldwide
Operations Ltd.
16
17
Attorneys for Novartis Vaccines and Diagnostics, Inc.
18
IN THE UNITED STATES DISTRICT COURT
19
IN AND FOR THE NORTHERN DISTRICT OF CALIFORNIA
20
SAN FRANCISCO DIVISION
21
22
23
24
25
ABBVIE INC.,
Case No. 3:17-CV-01815 EMC
Plaintiff,
v.
NOVARTIS VACCINES AND
DIAGNOSTICS, INC. and GRIFOLS
WORLDWIDE OPERATIONS LTD.,
Defendants.
STIPULATION & [PROPOSED]
ORDER TO MODIFY BRIEFING
SCHEDULE AND HEARING DATE
FOR MOTION TO COMPEL
ARBITRATION AND TO STAY
26
27
28
STIPULATION & [PROPOSED] ORDER TO
MODIFY BRIEFING SCHED. & HEARING
DATE FOR MOTION TO COMPEL
CASE NO. 3:17-CV-01815 EMC
1
2
3
4
5
6
7
8
9
Additional co-counsel:
SHERMAN KAHN (SBN: 168924)
skahn@mkwllp.com
MAURIEL KAPOUYTIAN WOODS LLP
15 W. 26th Street, 7th Floor
New York, NY 10010
Tel: (212) 524-9309
Fax: (212)529-5132
JASON R. BARTLETT (SBN: 214530)
jbartlett@mkwllp.com
MARC J. PERNICK (SBN: 160591)
mpernick@mkwllp.com
MAURIEL KAPOUYTIAN WOODS LLP
275 Battery Street, Suite 480
San Francisco, CA 94111
Tel: (415) 738-6228
Fax: (415) 738-2315
11
12
ATTORNEYS AT LAW
M C D ERMOTT W ILL & E MERY LLP
10
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
-1-
STIPULATION & [PROPOSED] ORDER TO
MODIFY BRIEFING SCHED. & HEARING
DATE FOR MOTION TO COMPEL
CASE NO. 3:17-CV-01815 EMC
1
Plaintiff AbbVie Inc. (“AbbVie”), Defendant Novartis Vaccines and Diagnostics, Inc.
2
(“Novartis”) and Defendant Grifols Worldwide Operations Ltd. (“Grifols”) file this stipulated
3
request and respectfully ask the Court to modify the briefing schedule for Defendant Novartis’s
4
Motion to Compel Arbitration and to Stay (“Motion to Compel Arbitration”). As grounds, the
5
parties state as follows:
6
On June 5, 2017, Novartis filed its Motion to Compel Arbitration (ECF No. 48) in this
7
case. In view of the schedules of counsel and with consideration to the Court’s schedule over the
8
coming months, the undersigned counsel met, conferred and agreed to extend the briefing
9
schedule and hearing date as follows:
Event
6/19/2017
7/7/2017
6/26/2017
7/21/2017
Motion Hearing
13
New Date
Replies Due
12
Original Date
Responses Due
11
ATTORNEYS AT LAW
M C D ERMOTT W ILL & E MERY LLP
10
7/13/2017, 1:30pm
8/17/2017, 1:30pm
14
15
16
17
18
19
20
21
22
23
24
In addition, on June 5, 2017, the parties also filed a stipulated request to stay the
proceedings in this case pending resolution of the Motion To Compel Arbitration and to Stay,
which the Court granted on June 6, 2017. (ECF No. 53) (“Pursuant to Stipulation, all scheduling
requirements are stayed until the Court issues its ruling on Novartis’ Motion To Compel
Arbitration and to Stay”). On that same date, however, a Clerk’s Notice was entered stating that
the Case Management Conference is reset to August 24, 2017 with the Case Management
Statement due on August 17, 2017. (ECF No. 54) Given the Court’s June 6, 2017 Order staying
“all scheduling requirements” in this case “until the Court issues its ruling on Novartis’ Motion
To Compel Arbitration and to Stay,” the parties respectfully request that the June 6, 2017 Clerk’s
Notice setting the Case Management Conference be vacated.
25
26
Grifols respectfully continues to reserve its right to challenge service of process in this
case.
27
28
-2-
STIPULATION & [PROPOSED] ORDER TO
MODIFY BRIEFING SCHED. & HEARING
DATE FOR MOTION TO COMPEL
CASE NO. 3:17-CV-01815 EMC
WHEREFORE, the parties respectfully request that, for good cause shown, the Court
1
grant this stipulated request.
2
3
4
Dated: June 8, 2017
Respectfully submitted,
5
6
7
8
MCDERMOTT WILL & EMERY LLP
By:
/s/ Thomas P. Steindler
Thomas P. Steindler
Attorneys for Novartis Vaccines and Diagnostics, Inc.
9
11
12
ATTORNEYS AT LAW
M C D ERMOTT W ILL & E MERY LLP
10
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
-3-
STIPULATION & [PROPOSED] ORDER TO
MODIFY BRIEFING SCHED. & HEARING
DATE FOR MOTION TO COMPEL
CASE NO. 3:17-CV-01815 EMC
LATHAM & WATKINS LLP
1
2
3
By:
/s/ Gregory K. Sobolski
Gregory K. Sobolski
Attorneys for AbbVie Inc.
4
5
6
7
/s/ Andrea Meghrouni-Brown
Andrea Meghrouni-Brown
Attorney for Grifols Worldwide Operations Ltd.
8
9
11
12
ATTORNEYS AT LAW
M C D ERMOTT W ILL & E MERY LLP
10
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
-4-
STIPULATION & [PROPOSED] ORDER TO
MODIFY BRIEFING SCHED. & HEARING
DATE FOR MOTION TO COMPEL
CASE NO. 3:17-CV-01815 EMC
1
SIGNATURE ATTESTATION
2
3
4
5
Pursuant to General Order 45.X(B), I hereby attest that concurrence has been obtained
from Gregory K. Sobolski and Andrea Meghrouni-Brown indicated by the “conformed”
signatures (/s/) within this e-filed document.
/s/ Thomas P. Steindler
Thomas P. Steindler
6
7
8
9
11
12
ATTORNEYS AT LAW
M C D ERMOTT W ILL & E MERY LLP
10
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
-5-
STIPULATION & [PROPOSED] ORDER TO
MODIFY BRIEFING SCHED. & HEARING
DATE FOR MOTION TO COMPEL
CASE NO. 3:17-CV-01815 EMC
1
[PROPOSED] ORDER
2
3
Pursuant to Stipulation, the briefing schedule for Novartis’ Motion to Compel Arbitration
and to Stay has been modified as follows:
4
Event
6/19/2017
7/7/2017
6/26/2017
7/21/2017
Motion Hearing
7
New Date
Replies Due
6
Original Date
Responses Due
5
7/13/2017, 1:30pm
8/17/2017, 1:30pm
8
9:30 a.m. A joint CMC statement
shall be filed by 11/9/17.
IT IS SO ORDERED.
Date:
14
ard M.
NO
17
RT
DM_US 82443209-5.085448.0181
dw
Judge E
H
ER
20
R NIA
IT IS
DIFIED
AS MO
Chen
FO
16
19
S DISTRICT
TE
C
TA
The Honorable Edward M. Chen
ED
United States ORDER
O District Judge
S
15
18
S
6/8/17
13
UNIT
ED
ATTORNEYS AT LAW
12
LI
11
Management Conference is hereby VACATED. reset from 8/24/17 to 11/16/17 at
RT
U
O
M C D ERMOTT W ILL & E MERY LLP
10
In addition, the Clerk’s Notice dated June 6, 2017 (ECF No. 54) setting a date for the Case
A
9
N
F
D IS T IC T O
R
C
21
22
23
24
25
26
27
28
-6-
STIPULATION & [PROPOSED] ORDER TO
MODIFY BRIEFING SCHED. & HEARING
DATE FOR MOTION TO COMPEL
CASE NO. 3:17-CV-01815 EMC
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?